Phase I trial of a dual TOR kinase and DNA-PK inhibitor (CC-115) in advanced solid and hematologic cancers Meeting Abstract


Authors: Munster, P. N.; Mahipal, A.; Nemunaitis, J. J.; Mita, M. M.; Paz-Ares, L. G.; Massard, C.; Mikkelsen, T.; Cruz, C.; Rathkopf, D. E.; Blumenschein, G. R.; Hidalgo, M.; Smith, D. C.; Eichhorst, B.; Cloughesy, T. F.; Garrick, B.; Trowe, T.; Filvaroff, E.; Hege, K.; Bendell, J. C.
Abstract Title: Phase I trial of a dual TOR kinase and DNA-PK inhibitor (CC-115) in advanced solid and hematologic cancers
Meeting Title: 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 15 Suppl.
Meeting Dates: 2016 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-05-20
Start Page: 115s
Language: English
ACCESSION: WOS:000404665403104
DOI: 10.1200/JCO.2016.34.15_suppl.2505
PROVIDER: wos
Notes: Meeting Abstract: 2505 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dana Elizabeth Rathkopf
    272 Rathkopf